Calcineurin Inhibition Attenuates Mineralocorticoid-Induced Cardiac Hypertrophy

Abstract

These results suggest that calcineurin is involved in the development of cardiac hypertrophy and fibrosis induced by mineralocorticoid excess. Inhibition of calcineurin may therefore prevent cardiac hypertrophy and fibrosis in mineralocorticoid hypertension.